Harmony Biosciences Holdings, Inc.
HRMY
$34.10
$1.715.28%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 899.11M | 868.45M | 825.94M | 772.53M | 744.85M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 899.11M | 868.45M | 825.94M | 772.53M | 744.85M |
| Cost of Revenue | 210.86M | 198.34M | 184.21M | 167.33M | 161.33M |
| Gross Profit | 688.25M | 670.11M | 641.74M | 605.19M | 583.53M |
| SG&A Expenses | 274.30M | 272.05M | 241.77M | 238.58M | 230.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 709.59M | 659.98M | 600.31M | 550.67M | 549.81M |
| Operating Income | 189.52M | 208.47M | 225.64M | 221.86M | 195.04M |
| Income Before Tax | 197.57M | 215.06M | 230.46M | 225.14M | 197.20M |
| Income Tax Expenses | 51.96M | 56.38M | 44.78M | 44.24M | 44.48M |
| Earnings from Continuing Operations | 145.62 | 158.69 | 185.68 | 180.90 | 152.72 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 145.62M | 158.69M | 185.68M | 180.90M | 152.72M |
| EBIT | 189.52M | 208.47M | 225.64M | 221.86M | 195.04M |
| EBITDA | 214.85M | 233.80M | 249.51M | 245.73M | 218.99M |
| EPS Basic | 2.53 | 2.76 | 3.24 | 3.16 | 2.68 |
| Normalized Basic EPS | 2.14 | 2.34 | 2.51 | 2.46 | 2.16 |
| EPS Diluted | 2.48 | 2.71 | 3.18 | 3.10 | 2.62 |
| Normalized Diluted EPS | 2.11 | 2.29 | 2.46 | 2.41 | 2.12 |
| Average Basic Shares Outstanding | 230.47M | 229.97M | 229.43M | 228.75M | 228.08M |
| Average Diluted Shares Outstanding | 234.62M | 234.37M | 233.89M | 233.27M | 232.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |